Region Vaermland — Clinical Trial Site

25 Registered trials

15 Currently recruiting

Organisation

Region Vaermland

Location

Karlstad, Sweden

Identifier

ORG-100049031

Address

Rosenborgsgatan 50, 652 33, Sweden

Departments

"Njurmedicinkliniken Centralsjukhuset i Karlstad"
Barndagvården, Centralsjukhuset
Centralsjukhuset Karlstad, Kirurgkliniken
Centralsjukhuset Karlstad, Neurologi och Rehabiliteringskliniken
Centralsjukhuset; Neurologi och rehabiliteringskliniken
Department of Gastroenterology
Department of Oncology
Department of Ophtalmology, Rosenborgsgatan, Centralsjukhuset, 652 30 Karlstad
Department of Vascular Surgery, Karlstad Central Hospital
Diabetescentrum, Rosenborgsgatan 2, Karlstad, 65233, Sweden
District Hospital Karlstad, Rosenborgsgatan 2, 651 85 Karlstad
Hjärtkliniken
Hjärtmottagningen
Infektionskliniken, Centralsjukhuset Karlstad
NA
Neurologi och Rehabiliteringskliniken
Neurology, Avd 59, Centralsjukhuset, Rosenborgsgatan Karlstad
Njurmedicinkliniken
Oncology
Onkologikliniken, Centralsjukhuset, Karlstad
Psykiatrisk öppen-/slutenvård
Region Värmland
Surgical Departmen
Vårdcentralen Kristinehamn, Solrosbacken 1, 681 80 Kristinehamn

Clinical trials at this site (25)

Search interface

ALASCCA-A randomized double-blind placebo-controlled study with ASA treatment in colorectal cancer patients with mutations in the PI3K signa… Pending

2024-513778-23-00 Colon and rectal cancer tumor stage II-III, tumor with 5
SGLT2 inhibitor or metformin as standard treatment in early type 2 diabetes (SMARTEST) Pending

2024-516228-33-00 Type 2 Diabetes 6
HiHat trial Pending

2024-519700-28-01 Patients with relapsing-remitting multiple sclerosis wi 4
Efficacy and Safety of a New Formulation of Oral Cladribine Compared with Placebo in Participants with Generalized Myasthenia Gravis (MyCla… Recruiting

2023-507746-83-00 Generalized Myasthenia Gravis 5 2024-11-27
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in … Recruiting

2024-511182-10-01 Pediatric cancer 6 2025-05-22
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting

2023-506460-14-00 Chronic kidney disease (CKD) and hypertension. 5 2025-05-07
Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated gl… Recruiting

2023-506998-35-00 Glioblastoma 5 2025-01-08
Concomitant HPV vaccination and HPV screening for rapid elimination of HPV infection and cervical cancer in Sweden Recruiting

2024-518857-41-00 HPV infection and related diseases, such as cervical in 6 2024-11-29
Assessment of short immunotherapy after radical surgery of high-risk malignant melanoma Recruiting

2023-509994-22-00 cutaneous malignant melanoma 5 2024-11-15
Improved Recovery by Iron following Surgery with blood loss, a double-blind multi-centre randomized controlled phase III drug trial (the IRI… Recruiting

2022-502776-22-00 Anemia 5 2024-09-05
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
Alternative antibiotics to multidrug-resistant UTIs Recruiting

2024-513294-41-00 Urinary tract infection and/or bacteremia caused by ext 6 2023-04-17
SACK Recruiting

2022-501600-10-00 Atrial fibrillation and Chronic Kidney Disease stage 5 5 2023-02-07
OPTION – OutPatienT InductiON: Labour induction in an outpatient setting - a multicentre randomized controlled trial Recruiting

2023-507164-39-00 Induction of labour 6 2021-12-01
PiSCATIN - Simvastatin for the treatment of primary sclerosing cholangitis (PSC) - a randomized double-blind, placebo-controlled multicenter… Recruiting

2024-511053-22-00 Primary sclerosing cholangitis (PSC) 4 2020-05-04
Does metformin reduce growth rate of small abdominal aortic aneurysms? Recruiting

2024-517387-37-00 Small abdominal aortic aneurysm (AAA) under active surv 4 2019-12-12
ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer Recruiting

2023-506857-40-00 Prostate Cancer 5 2019-01-08
A randomized controlled trial with Rituximab for Psychotic disorder in adults Ended

2024-512408-20-00 Schizophrenia spectrum disorder (SSD) 4 2024-08-27
Ixekizumab Diabetes Intervention Trial (I-DIT) Ended

2023-508588-58-00 Diabetes type 1 4 2022-10-25
A Randomized Intervention, Multi-Center Study to Determine the Role of Dexamethasone eye drops against proliferative retinopathy of prematur… Ended

2023-505318-97-00 Retinopathy of Prematurity 5 2022-09-22
A translational RANDOMIZED phase III study exploring the effect of the addition of capecitabine to Carboplatinum based chemotherapy in early… Ended

2022-501102-35-00 Early triple negative breast cancer 5 2019-12-02
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction SPIRRIT-HFpEF Ended

2024-517448-79-00 Heart failure with preserved ejection fraction 5 2017-11-23
A phase 3, randomised, double-blind, placebo-controlled, parallel-arm efficacy trial of Imatinib in acute ischaemic stroke Halted

2023-506178-11-00 Acute ischemic stroke 5 2025-11-11